These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8573622)

  • 1. Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex.
    Cao L; Zheng ZC; Zhao YC; Jiang ZH; Liu ZG; Chen SD; Zhou CF; Liu XY
    Hum Gene Ther; 1995 Nov; 6(11):1497-501. PubMed ID: 8573622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
    Zhang Y; Calon F; Zhu C; Boado RJ; Pardridge WM
    Hum Gene Ther; 2003 Jan; 14(1):1-12. PubMed ID: 12573054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental study on rat model of parkinsonism by gene therapy.
    Xu Q; Tian J; Zhang J; Yang H; Zheng S; Liu Y
    Chin Med J (Engl); 1998 Feb; 111(2):154-9. PubMed ID: 10374378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.
    Imaoka T; Date I; Ohmoto T; Nagatsu T
    Hum Gene Ther; 1998 May; 9(7):1093-102. PubMed ID: 9607420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term phenotypic correction of rodent hemiparkinsonism by gene therapy using genetically modified myoblasts.
    Cao L; Zhao YC; Jiang ZH; Xu DH; Liu ZG; Chen SD; Liu XY; Zheng ZC
    Gene Ther; 2000 Mar; 7(5):445-9. PubMed ID: 10694827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.
    Lundberg C; Horellou P; Mallet J; Björklund A
    Exp Neurol; 1996 May; 139(1):39-53. PubMed ID: 8635567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease.
    Zhang S; Zou Z; Jiang X; Xu R; Zhang W; Zhou Y; Ke Y
    Cell Mol Neurobiol; 2008 Jun; 28(4):529-43. PubMed ID: 17713852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.
    Wolff JA; Fisher LJ; Xu L; Jinnah HA; Langlais PJ; Iuvone PM; O'Malley KL; Rosenberg MB; Shimohama S; Friedmann T
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):9011-4. PubMed ID: 2573072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of foreign tyrosine hydroxylase gene in the rat model of Parkinson's disease].
    Jiang ZH; Ni ZM; Zhou CF; Cao L; Zheng ZC; Liu XY; Zhao YC; Chen SD
    Sheng Li Xue Bao; 1997 Apr; 49(2):141-5. PubMed ID: 9812848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomes.
    Xia CF; Chu C; Li J; Wang Y; Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2007 Jul; 9(7):605-12. PubMed ID: 17471587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.
    Segovia J; Vergara P; Brenner M
    Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study.
    Zou Z; Jiang X; Zhang W; Zhou Y; Ke Y; Zhang S; Xu R
    Brain Res; 2010 Jul; 1346():279-86. PubMed ID: 20570658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease.
    Schwarz EJ; Alexander GM; Prockop DJ; Azizi SA
    Hum Gene Ther; 1999 Oct; 10(15):2539-49. PubMed ID: 10543618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.
    Li XG; Okada T; Kodera M; Nara Y; Takino N; Muramatsu C; Ikeguchi K; Urano F; Ichinose H; Metzger D; Chambon P; Nakano I; Ozawa K; Muramatsu S
    Mol Ther; 2006 Jan; 13(1):160-6. PubMed ID: 16182609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells].
    Huang Y; Chang C; Zhang JW; Gao XQ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2353-6. PubMed ID: 23158567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.